Form 4: Merit Medical Systems Director Thomas James Gunderson Reports Stock Transactions

Director Thomas James Gunderson reports the acquisition and disposition of Merit Medical Systems (MMSI) stock and stock options.

Summary

• On March 4, 2024, Thomas James Gunderson, a director of Merit Medical Systems Inc. (MMSI), engaged in transactions involving the company's stock.
• Gunderson acquired 25,000 shares of common stock at a price of $34.40 per share through the exercise of non-qualified stock options.
• Simultaneously, Gunderson disposed of 18,157 shares of common stock at a weighted average price of $76.032 per share, with prices ranging from $76.00 to $76.25.
• Following these transactions, Gunderson directly owns 19,257 shares of Merit Medical Systems Inc.
• Gunderson also holds non-qualified stock options for 46,250 shares.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. The sentiment is neither positive nor negative as it simply reflects the director's activity.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly listed companies like Merit Medical Systems.
• Comparing Gunderson's transactions to those of insiders at similar medical device companies (e.g., Medtronic, Stryker) would require analyzing their respective Form 4 filings.
• The size and frequency of these transactions are typical for directors exercising stock options and managing their personal portfolios.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, as insider activity is often scrutinized for signals about company performance.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates